CIC
RPRX icon

Canal Insurance Company’s Royalty Pharma RPRX Stock Holding History

Canal Insurance Company’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Hold
20,000
– – 0.25% 60
2026
Q1 		$959K Buy
+20,000
New +$876K 0.21% 61

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canal Insurance Company's RPRX Position: Q2 2026 in Review

Canal Insurance Company held its Royalty Pharma (RPRX) position steady in Q2 2026 at 20,000 shares worth $1.12M. The position accounts for 0.25% of the portfolio, ranked #60.

Canal Insurance Company first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Canal Insurance Company held 20,000 shares of Royalty Pharma worth $1.12M as of Q2 2026.
  • Canal Insurance Company left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up 0.25% of Canal Insurance Company's portfolio in Q2 2026, its #60 holding.
  • Canal Insurance Company first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Canal Insurance Company's 13F filing for Q2 2026, filed 21 Jul 2026.